Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure
about
Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.Association of Serum Phosphate and Related Factors in ESRD-Related Vascular CalcificationHigh phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease.Biodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal FailurePhosphate: an old bone molecule but new cardiovascular risk factor.Bone-seeking agents for the treatment of bone disorders.PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy.Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification.La(iii) biodistribution profiles from intravenous and oral dosing of two lanthanum complexes, La(dpp)3 and La(XT), and evaluation as treatments for bone resorption disorders.Lanthanum chloride impairs spatial memory through ERK/MSK1 signaling pathway of hippocampus in rats.Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia.Inhibitory Effects of Lanthanum Chloride on Wear Particle-Induced Osteolysis in a Mouse Calvarial Model.Lanthanum carbonate stimulates bone formation in a rat model of renal insufficiency with low bone turnoverImpact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone diseaseEarly molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice
P2860
Q33580238-D9E8A7B3-231F-4328-BAC7-59FF714070A0Q35024959-AD8D6071-7F33-4271-AD6E-77EDECB003AFQ36516021-076519AC-A47F-44B0-BC29-6B29A0BC74FAQ36925093-E4712D34-8B1A-4334-9EA7-15895E748B62Q37492019-97D90093-E3F4-4181-A997-0F436820E7DFQ39356298-31E916E2-82F4-4B4C-BD42-615572649DA3Q41007103-2F107083-C13C-4D86-B29E-BFC003A88BCFQ42814528-242958C7-79BD-42E0-88D1-D3DEA502876DQ46915404-DE64813B-214C-4834-9E07-92EC228D884FQ48023175-E7D94F93-5E05-4C52-B838-0B9F23708984Q50628774-411DB6EB-FB38-40F1-B029-3BA054B59B09Q51025105-9A5C5634-4A0C-4227-9510-781DA2279E61Q53199958-427B3965-F60D-41DD-8AA1-B554D8D80CB7Q57216815-45222926-D129-4685-A332-35B0328B33BBQ57217879-C78CAEBF-4C41-4DC9-8650-CA2D9F9FFE85Q57777665-32210BC6-DD7A-41EE-9BBA-8E204C4DEAC7
P2860
Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Long-term treatment with lanth ...... ats with chronic renal failure
@en
Long-term treatment with lanth ...... ats with chronic renal failure
@nl
type
label
Long-term treatment with lanth ...... ats with chronic renal failure
@en
Long-term treatment with lanth ...... ats with chronic renal failure
@nl
prefLabel
Long-term treatment with lanth ...... ats with chronic renal failure
@en
Long-term treatment with lanth ...... ats with chronic renal failure
@nl
P2093
P2860
P356
P1476
Long-term treatment with lanth ...... ats with chronic renal failure
@en
P2093
Mariano Rodriguez
Roger Secker
Stephen Damment
Victor Lorenzo
Victor Shen
P2860
P304
P356
10.1093/NDT/GFQ682
P407
P577
2010-11-22T00:00:00Z